Changes in Hong Kong stocks | Minimally Invasive Healthcare (00853) fell nearly 4%, with a medium-term loss of up to 50 million US dollars to complete the gamble and it would take to earn 140 million US dollars in the second half of the year

The Zhitong Finance App learned that Minimally Invasive Medicine (00853) fell by nearly 4%. As of press release, it fell 3.68% to HK$6.42, with a turnover of HK$36.0093 million.

According to the news, Minimally Invasive Healthcare recently released a performance forecast. It is estimated that in the first half of the year, the revenue from continuing operations will increase by about 12% to 14% year on year, and the overseas business will contribute about 140% of growth; the net operating profit from the continuing business will not be less than 24 million US dollars. The net loss is expected to be no more than 50 million US dollars during the continuing operation period, and the loss amount increased by 49 million US dollars in the same period last year.

It is worth noting that the company previously accepted loans and financing from various parties such as Gao Lin Capital, and also signed a gambling agreement: in the three years from 2024 to 2026, minimally invasive medical treatment needed to achieve a loss of no more than US$275 million, a loss of no more than US$55 million, and a profit of US$90 million. According to this agreement, according to Minimally Invasive Healthcare's forecast for the first half of the year, the net loss is no more than 50 million US dollars, which means that a net profit of at least 140 million US dollars is required in the second half of the year to complete the gamble.